The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Epidemiologic aspects of human T-lymphotropic virus type I (HTLV-I) infection have been
thoroughly studied over the course of approximately 25 years since its first description. The …

Findings from the field of evolutionary biology are yielding dramatic insights for health
scientists, especially those involved in the fight against infectious diseases. This book is the …

It is estimated that viral infections contribute to 15–20% of all human cancers. As obligatory
intracellular parasites, viruses encode proteins that reprogram host cellular signaling …

It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

We have studied the genetic variation of human T-cell leukemia/lymphoma virus type I
(HTLV-I) isolates in the same individuals over time, as well as of HTLV-I isolates from …

Infection with human T-cell lymphotrophic virus-I (HTLV-I) is now a global epidemic, affecting
10 million to 20 million people. This virus has been linked to life-threatening, incurable …

Infection of cattle with the bovine leukemia virus (BLV) results in a strong permanent
antibody response to the BLV antigens some weeks after infection. However, cattle may …

▪ Purpose: To review the clinical, epidemiologic, immunologic, and virologic aspects of the
chronic myelopathy associated with human T-cell leukemia/lymphoma virus type I (HTLV-I) …

Evidence for human T celllymphotropic viruses (HTLV) was sought in sera and cells
collected from adults in 13 isolated South and Central American Indian tribes. Serologic …